Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 2
2014 2
2015 1
2016 3
2018 1
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
ITCH deficiency protects from diet-induced obesity.
Marino A, Menghini R, Fabrizi M, Casagrande V, Mavilio M, Stoehr R, Candi E, Mauriello A, Moreno-Navarrete JM, Gómez-Serrano M, Peral B, Melino G, Lauro R, Fernandez Real JM, Federici M. Marino A, et al. Among authors: fabrizi m. Diabetes. 2014 Feb;63(2):550-61. doi: 10.2337/db13-0802. Epub 2013 Oct 29. Diabetes. 2014. PMID: 24170694 Free article.
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.
Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, Menghini R, Federici M. Mavilio M, et al. Among authors: fabrizi m. Cell Rep. 2016 Jul 19;16(3):731-43. doi: 10.1016/j.celrep.2016.06.027. Epub 2016 Jun 30. Cell Rep. 2016. PMID: 27373162 Free article.
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay.
Fiorentino L, Cavalera M, Menini S, Marchetti V, Mavilio M, Fabrizi M, Conserva F, Casagrande V, Menghini R, Pontrelli P, Arisi I, D'Onofrio M, Lauro D, Khokha R, Accili D, Pugliese G, Gesualdo L, Lauro R, Federici M. Fiorentino L, et al. Among authors: fabrizi m. EMBO Mol Med. 2013 Mar;5(3):441-55. doi: 10.1002/emmm.201201475. Epub 2013 Feb 12. EMBO Mol Med. 2013. PMID: 23401241 Free PMC article.
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.
Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, Menghini R, Federici M. Mavilio M, et al. Among authors: fabrizi m. Cell Rep. 2016 Aug 23;16(8):2269. doi: 10.1016/j.celrep.2016.07.078. Epub 2016 Aug 29. Cell Rep. 2016. PMID: 27558826 Free article. No abstract available.
FoxO1 regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in human endothelial cells and subjects with atherosclerosis.
Menghini R, Casagrande V, Cardellini M, Ballanti M, Davato F, Cardolini I, Stoehr R, Fabrizi M, Morelli M, Anemona L, Bernges I, Schwedhelm E, Ippoliti A, Mauriello A, Böger RH, Federici M. Menghini R, et al. Among authors: fabrizi m. Atherosclerosis. 2015 Sep;242(1):230-5. doi: 10.1016/j.atherosclerosis.2015.07.026. Epub 2015 Jul 16. Atherosclerosis. 2015. PMID: 26226438
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity.
Fabrizi M, Marchetti V, Mavilio M, Marino A, Casagrande V, Cavalera M, Moreno-Navarrete JM, Mezza T, Sorice GP, Fiorentino L, Menghini R, Lauro R, Monteleone G, Giaccari A, Fernandez Real JM, Federici M. Fabrizi M, et al. Diabetes. 2014 Jun;63(6):2086-96. doi: 10.2337/db13-0939. Epub 2014 Jan 15. Diabetes. 2014. PMID: 24430438 Free article.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page